22.08.2023
Publications category: Pharmacometrics
14.06.2023
How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example
14.06.2023
Population Pharmacokinetics and Exposure-Response Relationships of Astegolimab in Patients with Severe Asthma
14.06.2023
Population pharmacokinetic analysis of etrolizumab in patients with moderately-to-severely active ulcerative colitis [2]
14.06.2023
Efficient and relevant stepwise covariate model building for pharmacometrics [1]
14.06.2023
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke
14.06.2023
Rituximab pharmacokinetic and pharmacokinetic–pharmacodynamic evaluation based on a study in diffuse large B-cell lymphoma: Influence of tumor size on pharmacokinetic and assessment of pharmacokinetic similarity
14.06.2023
Imeglimin Population Pharmacokinetics and Dose Adjustment Predictions for Renal Impairment in Japanese and Western Patients with Type 2 Diabetes
14.06.2023
Population Pharmacokinetic/Pharmacodynamic Modeling of the Psychedelic Experience Induced by N,N-dimethyltryptamine – Implications for Dose Considerations
14.06.2023
Exposure–Response Analyses for the MET Inhibitor Tepotinib Including Patients in the Pivotal VISION Trial: Support for Dosage Recommendations
14.06.2023